Cynthia St. Hilaire, Ph.D., Shira G. Ziegler, B.A., Thomas C. Markello, M.D., Ph.D., Alfredo Brusco, Ph.D., Catherine Groden, M.S., Fred Gill, M.D., Hannah Carlson-Donohoe, B.A., Robert J. Lederman, M.D., Marcus Y. Chen, M.D., Dan Yang, M.D., Ph.D., Michael P. Siegenthaler, M.D., Carlo Arduino, M.D., Cecilia Mancini, M.Sc., Bernard Freudenthal, M.D., Horia C. Stanescu, M.D., Anselm A. Zdebik, M.D., Ph.D., R. Krishna Chaganti, M.D., Robert L. Nussbaum, M.D., Robert Kleta, M.D., Ph.D., William A. Gahl, M.D., Ph.D., and Manfred Boehm, M.D.: NT5E Mutations and Arterial Calcifications.What’s more, significant falloff was noticed among dispensaries and patients that had been at the best end of the prescribing spectrum, the study noted. ‘There are no magic bullets when it comes to the opioid epidemic,’ acknowledged study lead author Dr. Caleb Alexander, co-director of the John Hopkins Center of Medication Safety and Effectiveness in Baltimore. ‘The problem is huge. America is just 5 % of the world’s inhabitants, but we eat 80 % of most opioids, and more People in america have passed away from opioid abuse than double the quantity who died in Iraq, Vietnam and Afghanistan combined,’ Alexander said. ‘But these kinds of policies and applications,’ he added, ‘are one of many tools states need to fight the nagging problem.